Researchers at Helmholtz Munich, in collaboration with colleagues at Tohoku University, have identified a specific redox protein as a critical regulator of ferroptosis – a form of regulated oxidative cell death.
Updated: Sage reports Phase 2 failure in Huntington’s disease, ends drug’s development
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
November 21, 2024